Two companies are combining their unique expertise to develop intelligent e-skin patches to “self-sense” cardiac events in patients. The flexible patch platform will deliver a comprehensive understanding of both electrical and mechanical heart activities and has the potential to enable cardiologists to better monitor their patients.
Progress in miniaturising sensor technology has opened up new possibilities for monitoring vital signs outside the hospital environment. A subset of wearables are the so-called hearables – in-ear devices that are well suited for long-term monitoring as they are non-invasive, inconspicuous and easy to fasten. Hearables offer two major benefits: their proximity to the torso and vascular system of…
The CardioPart 12 WLAN is a 12-lead resting ECG which fits into your pocket. Its compact design is equipped with a brilliant touch screen display, bar code reader and available on a 24/7 basis. Learn more at www.amedtec.de.
Kobe University Hospital’s Dr. Makoto Nishimori and Project Assistant Professor Kunihiko Kiuchi et al. (of the Division of Cardiovascular Medicine, Department of Internal Medicine) have developed an AI that uses multiple kinds of test data to predict the location of surplus pathways in the heart called ‘accessory pathways’, which cause the heart to beat irregularly. In this study, the…
The term “Cardiology” means the division of science that converses functions, diseases and health activities related to heart. It is also connected with blood, arteries and veins, as blood is the vital component of human body, upon which the heart works and for it we survive. The world cardiology market includes cardiac biomarkers, interventional cardiology and cardiovascular devices. The…
Scientists at the Virginia Tech Carilion Research Institute (VTCRI) have found evidence that may disrupt conventional understanding about how electrical activity travels in the heart — a discovery that potentially can lead to new insight into medical problems such as heart arrhythmia and sudden cardiac death.
Move over, lab-on-a-chip and lab-on-paper. There’s a new diagnostic technology in research labs that is gaining credibility. It is called lab-on-skin technology and some scientists are quite excited about how it might be used for a variety of clinical purposes. A recent story published in ACS Nano titled, “Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health…
Not having to visit hospital daily, or stay there too long, can improve the lives of patients tremendously. The Vic Hospital Consortium, in Catalonia, Spain, has begun to use a new remote monitoring system that enables it to monitor patients wherever they are. European Hospital spoke with Enrique de la Vega, digital product manager at Catalonia’s technology centre Eurecat, the organisation…
In the year of its 40th anniversary, Schiller proudly presents an algorithm which immediately and accurately localises coronary occlusions and provides early detection of STEMI. This algorithm is now integrated in the sophisticated touch ECG devices, the Cardovit MS line.
In Switzerland, they say, the clocks tick a little slower than elsewhere in the world. Not at Schiller AG in Baar, however: The company remains forever ahead of the times. Since 1971, physicist Alfred E Schiller, the company’s founder and managing director, has successfully shown competitors in the tough intensive and emergency care market what innovative progress really means.
'I was very surprised!' said cardiologist Dr Maria Prokudina, of the Almazof Federal Centre of Heart, Blood and Endocrinology, when invited by Professor John Elefteriades MD, head of Department of Cardiothoracic Surgery at Yale-New Haven Hospital (University School of Medicine) to lecture about Stress Echocardiography in Clinical Practice.
Switzerland - A clinical trial of cardiac resynchronisation therapy (CRT) in patients with advanced heart failure and a narrow QRS complex
At the EH symposium, Dr Algayres will discuss:
Alfred E Schiller, founder and managing director of Schiller AG, based in Baar, Switzerland, describes the rise of his company and its place in today’s highly competitive intensive care market. Alfred Schiller founded Schiller AG in 1971 and three years later introduced his first product – a pocket-sized electrocardioscope, which has been built on successively over the years. The…
Article by Stefan G Ruehm MD, Associate Professor of Radiology, Director, Cardiovascular CT, at the David Geffen School of Medicine, UCLA.